What is intravenous immunoglobulin (IVIG) therapy and what types of autoimmune disease is it used to treat? IVIG is a hugely successful biological with FDA approval for treating idiopathic ...
A 52-year-old gentleman, who had been suffering from severe stiffness and difficulty walking for months, has shown a remarkable improvement following treatment with intravenous immunoglobulin (IVIG) ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Did you know that a component of your blood could be used ...
Neurologist Susan W. Lee, DO, answers common questions about this treatment option for myasthenia gravis. Intravenous immunoglobulin (IVIG) is a pooled collection of antibodies derived from donors’ ...
Intravenous immunoglobulin (IVIg) has been evaluated as an adjunctive therapy for neonatal sepsis with modest clinical success despite strong biological plausibility. Multiple factors contribute to ...
Prophylactic intravenous immunoglobulin reduces COVID-19 infection rates in older patients with DLBCL with hypogammaglobulinemia undergoing reduced-intensity R-CHOP therapy. The study, conducted ...
June 5, 2002 -- Intravenous immunoglobulin (IVIG) is effective in treating some forms of diabetic-related neuropathy, according to results of a study published in the May issue of the Archives of ...
With use of intravenous immune globulin (IVIg) for the treatment of adults with dermatomyositis, a significantly higher percentage of patients experienced at least minimal improvement in disease ...
Please provide your email address to receive an email when new articles are posted on . In a case study of three patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, starting ...
Please provide your email address to receive an email when new articles are posted on . IVIG had favorable effects on skin thickening, muscle and joint pain, and gastrointestinal symptoms of systemic ...
The IVIG products gained significant attention in the recent years due to their high efficacy in the treatment of immune diseases. PORTLAND, OREGON, UNITED STATES, September 9, 2022 /EINPresswire.com ...